Latest features

Most popular

CPD Articles

News

  • AbobotulinumtoxinA efficacy confirmed in phase 2 study

    Global pharmaceutical company Galderma has received top-line results for its phase 2 study in the US on the efficacy and safety of a single dose of abobotulinumtoxinA versus placebo for the treatment of moderate to severe glabellar lines.

  • Study supports microdose toxin efficacy

    A new study published in Plastic and Reconstructive Surgery has suggested that intradermal botulinum toxin injection, or microbotulinum, is a safe and effective method to treat skin flaws.

Jobs

    • No matching jobs were found.

Classifieds

    • No matching classifieds were found.

ACE Sessions

  • No matching ACE Sessions were found

Suppliers

  • No matching suppliers were found.

Training

  • No matching training events were found.